AGEN

SEC source: 0000899243-19-017822 · doc4.xml · derivative · entry 2

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,500

Underlying: Common Stock · 100,000 shares

Expires 2029-01-01

F1 · derivative.exercise_date: Option was granted on January 1, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan. The option vests on January 1, 2020.

SEC source: 0000899243-19-017822 · doc4.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2029-01-01

F1 · derivative.exercise_date: Option was granted on January 1, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan. The option vests on January 1, 2020.

SEC source: 0001745285-20-000005 · primary_doc.xml · derivative · entry 3

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,500

Underlying: Common Stock · 42,500 shares

Expires 2028-12-31

F4 · derivative.exercise_date: Option granted on December 31, 2018, subject to shareholder approval, which was obtained at Agenus Inc.'s annual shareholder meeting on June 19, 2019. Option awarded in accordance with Agenus Inc. 2009 Amended and Restated Equity Incentive Plan and one third of the option vested on January 1, 2020 and the balance will vest in equal quarterly installments thereafter; provided, however, that the unvested portion of such option shall vest in full upon Dr. Armen's death, disability or retirement.

SEC source: 0001745285-19-000006 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,568.918

Underlying: Common Stock · 2,471.541 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $3.161 per Deferred Stock Unit acquired on April 1, 2019. The price of each Deferred Stock Unit acquired prior to April 1, 2019 is the average of the closing price for the company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Units were acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001745285-19-000005 · primary_doc.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,674.953

Underlying: Common Stock · 6,129.421 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $3.161 per Deferred Stock Unit acquired on April 1, 2019. The price of each Deferred Stock Unit acquired prior to April 1, 2019 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Units were acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001745285-19-000004 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,045.366

Underlying: Common Stock · 6,327.144 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $3.161 per Deferred Stock Unit acquired on April 1, 2019. The price of each Deferred Stock Unit acquired prior to April 1, 2019 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Units were acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001745285-19-000003 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,382.227

Underlying: Common Stock · 3,382.227 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001745285-19-000002 · primary_doc.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,940.88

Underlying: Common Stock · 7,940.88 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001745285-19-000001 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,234.987

Underlying: Common Stock · 8,234.987 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-18-028888 · doc4.xml · derivative · entry 1

Buell Jennifer · CIK 0001711184 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,000

Underlying: Common Stock · 130,000 shares

Expires 2027-11-07

F1 · derivative.exercise_date: Represents the grant of an option to purchase shares of common stock. The stock option was awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Investment Plan, and vests over three years with one-third of the award vesting on November 7, 2019 and the balance vesting in equal quarterly installments thereafter.

SEC source: 0000899243-18-028886 · doc4.xml · derivative · entry 2

Jeynes-Ellis Allison M · CIK 0001758521 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2027-11-07

F2 · derivative.exercise_date: Represents the grant of an option to purchase shares of common stock. The stock option vests in three equal annual installments on each of November 7, 2019, 2020 and 2021.

SEC source: 0000899243-18-028886 · doc4.xml · nonDerivative · entry 1

Jeynes-Ellis Allison M · CIK 0001758521 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,985

F1 · price: The securities described are restricted stock units and will vest on November 7, 2019.

SEC source: 0001288123-18-000026 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,584.646

Underlying: Common Stock · 3,584.646 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001288123-18-000024 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,727.834

Underlying: Common Stock · 8,727.834 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001288123-18-000025 · primary_doc.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,416.126

Underlying: Common Stock · 8,416.126 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001745285-19-000018 · primary_doc.xml · nonDerivative · entry 3

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,296,433

F3 · kind: Represents deposit of Agenus Inc. common stock into the Garo Armen 2018 2 Year AG GRAT.

SEC source: 0001745285-19-000018 · primary_doc.xml · nonDerivative · entry 2

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,521,433

F2 · kind: Represents required distribution from the Garo Armen 2017 2 Year AG GRAT.

SEC source: 0001288123-18-000021 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,092.907

Underlying: Common Stock · 2,092.907 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001288123-18-000020 · primary_doc.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,913.781

Underlying: Common Stock · 4,913.781 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001288123-18-000019 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,095.773

Underlying: Common Stock · 5,095.773 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001288123-18-000014 · primary_doc.xml · derivative · entry 3

Sharp Shalini · CIK 0001377202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-06-21

SEC source: 0001288123-18-000012 · primary_doc.xml · derivative · entry 1

ARMEN GARO H · CIK 0000935679 · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 935,200

Underlying: Common Stock · 935,200 shares

Expires 2028-03-02

F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, and vests over three years with one-third of the award vesting on March 2, 2019 and the balance vesting in equal quarterly installments thereafter.

SEC source: 0001288123-18-000016 · primary_doc.xml · derivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,276

Underlying: Common Stock · 21,276 shares

Expires 2019-04-19

F2 · derivative.exercise_price: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019.

F2 · price: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019.

F2 · derivative.exercise_date: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019.

SEC source: 0001288123-18-000016 · primary_doc.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2028-03-02

F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, vesting on March 2, 2019.

SEC source: 0001288123-18-000017 · primary_doc.xml · derivative · entry 2

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,957

Underlying: Common Stock · 15,957 shares

Expires 2028-04-19

F2 · derivative.exercise_price: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019.

F2 · price: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019.

F2 · derivative.exercise_date: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019.

SEC source: 0001288123-18-000017 · primary_doc.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2028-03-02

F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, vesting on March 2, 2019.

SEC source: 0001288123-18-000014 · primary_doc.xml · derivative · entry 2

Sharp Shalini · CIK 0001377202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Sotck · 37,500 shares

Expires 2028-03-02

F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, vesting on March 2, 2019

SEC source: 0001288123-18-000015 · primary_doc.xml · derivative · entry 2

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,957

Underlying: Common Stock · 15,957 shares

Expires 2019-04-19

F2 · derivative.exercise_price: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meting on June 20, 2018. Award vests on April 19, 2019.

F2 · price: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meting on June 20, 2018. Award vests on April 19, 2019.

SEC source: 0001288123-18-000015 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2028-03-02

F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, vesting on March 2, 2019.

SEC source: 0001288123-18-000013 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2028-03-02

F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, vesting on March 2, 2019.

SEC source: 0001288123-18-000010 · primary_doc.xml · derivative · entry 1

KLASKIN CHRISTINE M · CIK 0001288123 · VP Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,150

Underlying: Common Stock · 83,150 shares

Expires 2018-03-02

F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, and vests over three years with one-third of the award vesting on March 2, 2019 and the balance vesting in equal quarterly installments thereafter.

SEC source: 0001288123-18-000011 · primary_doc.xml · derivative · entry 1

Duncan Alex · CIK 0001711183 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,000

Underlying: Common Stock · 165,000 shares

Expires 2028-03-02

F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, and vests over three years with one-third of the award vesting on March 2, 2019 and the balance vesting in equal quarterly installments thereafter.

SEC source: 0001288123-18-000009 · primary_doc.xml · derivative · entry 1

Buell Jennifer · CIK 0001711184 · Chief Communications Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2028-03-02

F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 equity Inventive Plan, and vests over three years with one-third of the award vesting on March 2, 2019 and the balance vesting in equal quarterly installments thereafter.

SEC source: 0001288123-18-000008 · primary_doc.xml · derivative · entry 1

Baysal Ozer · CIK 0001579446 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,000

Underlying: Common Stock · 165,000 shares

Expires 2028-03-02

F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, and vests over three years with one-third of the award vesting on March 2, 2019 and the balance vesting in equal quarterly installments thereafter.

SEC source: 0001288123-18-000007 · primary_doc.xml · derivative · entry 1

Valentine Karen · CIK 0001437152 · Chief Legal Officer and GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,150

Underlying: Common Stock · 173,150 shares

Expires 2028-03-02

F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, and vests over three years with one-third of the award vesting on March 2, 2019 and the balance vesting in equal quarterly installments thereafter.

SEC source: 0001288123-18-000022 · primary_doc.xml · derivative · entry 1

KLASKIN CHRISTINE M · CIK 0001288123 · VP Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,150

Underlying: Common Stock · 83,150 shares

Expires 2028-03-02

F2 · security: Amendment filed to correct previously reported expiration date of the award.

F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Options awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, and vests over three years with one-third of the award vesting on march 2, 2019 and the balance vesting in equal quarterly installments thereafter.

SEC source: 0001745285-19-000018 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,221,433

F1 · kind: Represents shares donated to a charitable organization.

SEC source: 0000899243-18-009228 · doc4.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,866.633

Underlying: Common Stock · 3,866.633 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-18-009227 · doc4.xml · derivative · entry 3

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,588.081

Underlying: Common Stock · 1,588.081 shares

Expires not disclosed

F1 · security: Each restricted stock unit represents a contingent right to receive one share of common stock.

F3 · derivative.exercise_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F3 · derivative.expiration_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-18-009223 · doc4.xml · derivative · entry 3

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,728.539

Underlying: Common Stock · 3,728.539 shares

Expires not disclosed

F1 · security: Each restricted stock unit represents a contingent right to receive one share of common stock.

F3 · derivative.exercise_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F3 · derivative.expiration_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-18-009227 · doc4.xml · derivative · entry 2

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,915 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2 · price: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 15,915 restricted stock units vested on March 31, 2018.

F2 · derivative.exercise_date: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 15,915 restricted stock units vested on March 31, 2018.

F2 · derivative.expiration_date: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 15,915 restricted stock units vested on March 31, 2018.

SEC source: 0000899243-18-009227 · doc4.xml · nonDerivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,581

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2 · price: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 15,915 restricted stock units vested on March 31, 2018.

SEC source: 0000899243-18-009224 · doc4.xml · derivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,220 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2 · price: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 21,220 restricted stock units vested on March 31, 2018.

F2 · derivative.exercise_date: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 21,220 restricted stock units vested on March 31, 2018.

F2 · derivative.expiration_date: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 21,220 restricted stock units vested on March 31, 2018.

SEC source: 0000899243-18-009224 · doc4.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,220

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2 · price: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 21,220 restricted stock units vested on March 31, 2018.

SEC source: 0000899243-18-009223 · doc4.xml · derivative · entry 2

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,915 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2 · price: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 15,915 restricted stock units vested on March 31, 2018.

F2 · derivative.exercise_date: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 15,915 restricted stock units vested on March 31, 2018.

F2 · derivative.expiration_date: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 15,915 restricted stock units vested on March 31, 2018.

SEC source: 0000899243-18-009223 · doc4.xml · nonDerivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,915

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2 · price: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 15,915 restricted stock units vested on March 31, 2018.

SEC source: 0001288123-18-000006 · primary_doc.xml · derivative · entry 1

Sharp Shalini · CIK 0001377202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,533

Underlying: Common Stock · 18,533 shares

Expires 2028-03-02

F1 · derivative.exercise_date: 100% of the options vest on the one-year anniversary of the grant date provide the director continues to serve as a director of the Company on that date.

SEC source: 0001288123-18-000014 · primary_doc.xml · derivative · entry 1

Sharp Shalini · CIK 0001377202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,533

Underlying: Common Stock · 18,533 shares

Expires 2028-03-02

SEC source: 0001288123-18-000001 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,500.367

Underlying: Common Stock · 4,500.367 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001288123-18-000003 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,848.365

Underlying: Common Stock · 1,848.365 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.